康寧醫院((2120.HK)漲近9% 謀求“A+H”兩地上市
格隆匯9月23日丨康寧醫院(2120.HK)今日盤中一度漲近9%報31港元,市值23億港元。公司9月16日發公吿稱,擬申請首次公開發行A股股票並在深交所創業板上市。此次發行上市全部為公開發行新股,擬公開發行股票數量不超過本次發行後公司股本總額的10%。康寧醫院此次首發擬募資3.02億元。值得注意的是,公司曾在2016年申請過A股上市。康寧醫院是一家民營精神病專科醫院,已於2015年11月登陸香港聯合交易所,是國內第一家精神專科醫院上市公司,如今已成為中國規模最大的精神病專科醫院。2020年財報顯示,康寧醫院自有醫院運營收入9.78億元,與2017年相比,規模翻了一番。截至2020年末,康寧醫院旗下醫療機構數量達到24家(包括1家獨立設置的互聯網醫院),運營牀位數增至7483張,歸屬於母公司股東的淨利潤7000萬元,較2019年增長22.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.